MIR3156-1

Across TCGA pan-cancer cohorts, MIR3156-1 RNA is linked to patient survival in 6 of 34 cancer types, making it the most broadly survival-associated MIR3156-1 data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher MIR3156-1 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MIR3156-1 expression acts as an unfavorable survival marker.

STAD, SKCM, and ESCA are the cancer types where MIR3156-1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	DFS	Tertile	II,III,IV	0.438	0.659	.001	63	view →
SKCM	DFS	Tertile	All	0.037	0.738	<.001	54	view →
ESCA	OS	Tertile	All	0.198	0.872	.003	36	view →
SARC	OS	Tertile	All	0.022	0.861	<.001	36	view →
LUSC	DFS	Tertile	All	0.145	0.748	.002	27	view →
UCS	OS	Tertile	All	0.185	0.686	.034	18	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

MIR3156-1–STAD (DFS)

Open the STAD breakdown →